MGNX MacroGenics, Inc.
$2.44▲ +11.42%
Healthcare
Other
After hours
$2.36▼ -3.28%
Oct 27, 4:40 PM ET
Volume 2.12M
Avg Volume (10D) 1.08M
Key Metrics & Fundamentals
Market Cap
$155.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.29 - 5.08
% vs 50 MA
-35.64%
% vs 200 MA
-28.40%
RSI-14
31.5
MACD Histogram
-0.1100
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$41.55M
Gross Rev
$32.83M
Gross Profit
$32.83M
EBITDA
-$11.78M
COGS
–
Operating Exp
$46.68M
Operating Income
-$13.85M
EBIT
-$13.85M
Pretax Income
-$69.64M
Net Income
$19.52M
EPS (Diluted)
0.31
Price & Volume History
Loading chart…
Recent News
MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
GlobeNewswire · Oct 26, 2026 7:06 AM ET
MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
GlobeNewswire · Oct 23, 2026 9:15 AM ET
MacroGenics Says First Patient Dosed in Phase 1 Study of MGC030 for Advanced Solid Tumors
MT Newswires · Oct 15, 2026 5:00 PM ET
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
GlobeNewswire · Oct 15, 2026 4:05 PM ET
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 9, 2026 8:40 AM ET
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Zacks · Sep 23, 2026 9:40 AM ET
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 9, 2026 4:05 PM ET
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Zacks · Aug 20, 2026 9:40 AM ET
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating
MT Newswires · Aug 17, 2026 7:49 AM ET
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
Insider Monkey · Aug 14, 2026 8:50 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MGNX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.